MAS Injects S$1.1B Into Singapore Equities. Here Are the Stocks Analysts Say Will Benefit Most
- ellaintan
- Jul 23
- 1 min read
On 21 July 2025, the Monetary Authority of Singapore (MAS) announced the appointment of the first three asset managers: JP Morgan Asset Management, Fullerton Fund Management, and Avanda Investment Management. These appointments are part of the S$5 billion Equity Market Development Programme (EQDP). A total of S$1.1 billion has been allocated to this initial group, with a strong mandate to improve liquidity in Singapore equities, especially small and mid-cap stocks.
In addition to the fund deployment, MAS committed S$50 million through the GEMS scheme to support the growth of equity research, investor access, and a wider product suite. Together, these measures represent one of the most comprehensive efforts to revitalise Singapore's equity market in recent years.
Which Stocks Could Benefit
Several research houses quickly issued commentary following the announcement. After reviewing notes from Maybank, CGS, UOB Kay Hian, and DBS, a number of commonly cited beneficiaries emerged. These are companies with strong fundamentals, exposure to the small and mid-cap space, and potential for growth or turnaround.
Below are the stocks mentioned by at least two analysts:
Also worth noting are names such as Valuetronics, Oiltek, PropNex, Raffles Medical, GuocoLand, SGX, and LHN, which were each flagged once but carry unique catalysts that align with the objectives of EQDP.
Final Thoughts
The EQDP is more than just a capital injection. It signals a renewed institutional push to rebuild confidence and activity in Singapore’s equity market. For investors looking to position ahead of a potential re-rating, the stocks consistently mentioned across broker reports may offer a solid starting point.
Comments